611240-68-7Relevant articles and documents
METHOD OF CONTROLLING HARMFUL ARTHROPOD USING HETEROCYCLIC COMPOUND
-
Paragraph 0313, (2020/11/28)
PROBLEM TO BE SOLVED: To provide a method of controlling harmful arthropods. SOLUTION: An effective amount of a compound represented by formula (I) or an N oxide thereof is applied to harmful arthropods, a habitat of harmful arthropods, plants or the soil, [where Q is a group represented by Q1, or a group represented by Q2; Z is O or the like; A2 is CR4a or the like; A3 is N or CR4b or the like; B1 is CR1 or the like; B2 is N or CR6b or the like; B3 is N or CR6c or the like; G1 is N or CR3a; G2 is N or CR3b; G3 is N or CR3c; G4 is N or CR3d; R1 is a C1-C6 chain hydrocarbon group substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom, or the like; R2 is a C1-C6 alkyl group or the like; R3a, R3b, R3c and R3d are the same or different to represent a C1-C6 chain hydrocarbon group or the like; R4a, R4b, R6b and R6c are the same or different to represent H or the like; n is 0, 1 or 2.] SELECTED DRAWING: None COPYRIGHT: (C)2021,JPOandINPIT
HARMFUL ARTHROPOD CONTROLLING METHOD USING HETEROCYCLIC COMPOUND
-
Paragraph 0263, (2019/11/13)
PROBLEM TO BE SOLVED: To provide a harmful arthropod controlling method. SOLUTION: Harmful arthropods can be controlled by a compound represented by formula (I): Q-Pyridyl (RS(O) substituted) [where Q is a group represented by the formula Q1 or a group re
Discovery of a potent, selective, and orally active phosphodiesterase 10A inhibitor for the potential treatment of schizophrenia
Bartolomé-Nebreda, José Manuel,Delgado, Francisca,Martín-Martín, María Luz,Martínez-Viturro, Carlos M.,Pastor, Joaquín,Tong, Han Min,Iturrino, Laura,Macdonald, Gregor J.,Sanderson, Wendy,Megens, Anton,Langlois, Xavier,Somers, Marijke,Vanhoof, Greet,Conde-Ceide, Susana
, p. 4196 - 4212 (2014/06/09)
We report the discovery of a series of imidazo[1,2-a]pyrazine derivatives as novel inhibitors of phosphodiesterase 10A (PDE10A). In a high-throughput screening campaign we identified the imidazopyrazine derivative 1, a PDE10A inhibitor with limited select